Zymeworks (ZYME) EBT Margin (2021 - 2026)

Zymeworks has disclosed EBT Margin across 6 years of filings, most recently posting 1924.96% for Q1 2026.

• EBT Margin for Q1 2026 came in at 1924.96%, down 121076.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 132.19% (up 5217.0% YoY), and the FY2025 annual result was 75.26%, up 7756.0% from the prior year.
• EBT Margin came in at 1924.96% for Q1 2026 at Zymeworks, down from 1649.26% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 98.6% in Q4 2022 to a low of 3794.31% in Q1 2022.
• The 5-year median for EBT Margin is 314.84% (2024), against an average of 772.92%.
• Across the five-year window, EBT Margin surged 372977 bps in 2023 and tumbled 159193 bps in 2025, its largest moves.
• Zymeworks' EBT Margin stood at 98.6% in 2022, then tumbled by 215 bps to 113.46% in 2023, then soared by 49 bps to 57.33% in 2024, then sank by 2777 bps to 1649.26% in 2025, then slipped by 17 bps to 1924.96% in 2026.
• The last three EBT Margin figures came in at 1924.96% (Q1 2026), 1649.26% (Q4 2025), and 73.06% (Q3 2025), per Business Quant data.